Keywords: Canada Competition Authority, Teva, Ratiopharm, Merckle

Canadian competition authority calls for Teva divestments to complete Ratiopharm acquisition

Article | 03 August 2010

Print This

The Competition Bureau in Canada has reached an agreement with Israeli generics giant Teva Pharmaceutical Industries and the Merckle Group ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in